Martin PM - Search Results

1

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

Foucré D, Bouchet C, Hacène K, Pourreau-Schneider N, Gentile A, Martin PM, Desplaces A, Oglobine J. Foucré D, et al. Among authors: martin pm. Br J Cancer. 1991 Nov;64(5):926-32. doi: 10.1038/bjc.1991.428. Br J Cancer. 1991. PMID: 1931618 Free PMC article.

2

[Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer].

Bouchet C, Spyratos F, Martin PM, Hacène K, Gentile A, Oglobine J. Bouchet C, et al. Among authors: martin pm. Bull Cancer. 1994 Sep;81(9):770-9. Bull Cancer. 1994. PMID: 7703566 French.

3

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.

Bouchet C, Spyratos F, Martin PM, Hacène K, Gentile A, Oglobine J. Bouchet C, et al. Among authors: martin pm. Br J Cancer. 1994 Feb;69(2):398-405. doi: 10.1038/bjc.1994.74. Br J Cancer. 1994. PMID: 8297742 Free PMC article.

4

Dissemination risk index based on plasminogen activator system components in primary breast cancer.

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. Among authors: martin pm. J Clin Oncol. 1999 Oct;17(10):3048-57. doi: 10.1200/JCO.1999.17.10.3048. J Clin Oncol. 1999. PMID: 10506599

5

[Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system].

Bouchet C, Hacène K, Martin PM, Becette V, Tubiana-Hulin M, Lasry S, Oglobine J, Spyratos F. Bouchet C, et al. Among authors: martin pm. Pathol Biol (Paris). 2000 Nov;48(9):825-31. Pathol Biol (Paris). 2000. PMID: 11141918 French.

6

Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.

Pourreau-Schneider N, Delori P, Boutière B, Arnoux D, George F, Sampol J, Martin PM. Pourreau-Schneider N, et al. Among authors: martin pm. J Natl Cancer Inst. 1989 Feb 15;81(4):259-66. doi: 10.1093/jnci/81.4.259. J Natl Cancer Inst. 1989. PMID: 2492346

7

Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.

Romain S, Spyratos F, Lainé-Bidron C, Bouchet C, Guirou O, Martin PM, Oglobine J, Magdelénat H. Romain S, et al. Among authors: martin pm. Eur J Clin Chem Clin Biochem. 1995 Sep;33(9):603-8. Eur J Clin Chem Clin Biochem. 1995. PMID: 8611670

8

Multiparametric prognostic evaluation of biological factors in primary breast cancer.

Spyratos F, Martin PM, Hacène K, Romain S, Andrieu C, Ferrero-Poüs M, Deytieux S, Le Doussal V, Tubiana-Hulin M, Brunet M. Spyratos F, et al. Among authors: martin pm. J Natl Cancer Inst. 1992 Aug 19;84(16):1266-72. doi: 10.1093/jnci/84.16.1266. J Natl Cancer Inst. 1992. PMID: 1640487

9

Concomitant secretion by A431 cells of tissue plasminogen activator and a specific inhibitor masks EGF modulation of tPA activity.

George F, Pourreau-Schneider N, Arnoux D, Boutière B, Berthois Y, Martin PM, Sampol J. George F, et al. Among authors: martin pm. Thromb Haemost. 1990 Nov 30;64(3):407-11. Thromb Haemost. 1990. PMID: 2128970

10

Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line.

George F, Pourreau-Schneider N, Arnoux D, Boutière B, Dussault N, Roux-Dosseto M, Alessi MC, Martin PM, Sampol J. George F, et al. Among authors: martin pm. Blood Coagul Fibrinolysis. 1990 Dec;1(6):689-93. Blood Coagul Fibrinolysis. 1990. PMID: 2133249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters